Impact of lipopolysaccharide-induced acute lung injury in aged mice

References

• Brandsma C-A, de Vries M, Costa R, Woldhuis RR, Königshoff M, Timens W. Lung ageing and COPD: is there a role for ageing in abnormal tissue repair? Eur Respir Rev. 2017;26(146):170073. doi:10.1183/16000617.0073-2017.
   PubMed Web of Science ®Google Scholar
• Lim JU, Lee J, Ha JH, Kang HH, Lee SH, Moon HS. Demographic changes in intensive care units in Korea over the last decade and outcomes of elderly patients: a single-center retrospective study. Korean J Crit Care Med. 2017;32(2):164–173. doi:10.4266/kjccm.2016.00668.
   PubMedGoogle Scholar
• Sharma G, Goodwin J. Effect of aging on respiratory system physiology and immunology. Clin Interv Aging. 2006;1(3):253–260. doi:10.2147/ciia.2006.1.3.253.
   PubMed Web of Science ®Google Scholar
• Freitas FS, Ibiapina CC, Alvim CG, Britto RR, Parreira VF. Relationship between cough strength and functional level in elderly. Rev Bras Fisioter. 2010;14(6):470–476. doi:10.1590/S1413-35552010000600004.
   PubMedGoogle Scholar
• Lowery EM, Brubaker AL, Kuhlmann E, Kovacs EJ. The aging lung. Clin Interv Aging. 2013;8:1489–1496. doi:10.2147/cia.S51152.
   PubMed Web of Science ®Google Scholar
• Brandenberger C, Muhlfeld C. Mechanisms of lung aging. Cell Tissue Res. 2017;367(3):469–480. doi:10.1007/s00441-016-2511-x.
   PubMed Web of Science ®Google Scholar
• Hecker L. Mechanisms and consequences of oxidative stress in lung disease: therapeutic implications for an aging populace. Am J Physiol Lung Cell Mol Physiol. 2018;314(4):L642–Ll653. doi:10.1152/ajplung.00275.2017.
   PubMed Web of Science ®Google Scholar
• Lee JY, Yoo CG, Kim HJ, Jung KS, Yoo KH. Disease burden of pneumonia in Korean adults aged over 50 years stratified by age and underlying diseases. Korean J Intern Med. 2014;29(6):764–773. doi:10.3904/kjim.2014.29.6.764.
   PubMed Web of Science ®Google Scholar
• Meyer KC. Aging. Proc Am Thorac Soc. 2005;2(5):433–439. doi:10.1513/pats.200508-081JS.
   PubMedGoogle Scholar
• Brunker LB, Boncyk CS, Rengel KF, Hughes CG. Elderly patients and management in intensive care units (ICU): Clinical challenges. Clin Interv Aging. 2023;18:93–112. doi:10.2147/cia.S365968.
   PubMed Web of Science ®Google Scholar
• Laporte L, Hermetet C, Jouan Y, et al. Ten-year trends in intensive care admissions for respiratory infections in the elderly. Ann Intensive Care. 2018;8(1):84. doi:10.1186/s13613-018-0430-6.
   PubMed Web of Science ®Google Scholar
• Guillon A, Hermetet C, Barker KA, et al. Long-term survival of elderly patients after intensive care unit admission for acute respiratory infection: a population-based, propensity score-matched cohort study. Crit Care. 2020;24(1):384. doi:10.1186/s13054-020-03100-4.
   PubMed Web of Science ®Google Scholar
• Ely EW, Wheeler AP, Thompson BT, Ancukiewicz M, Steinberg KP, Bernard GR. Recovery rate and prognosis in older persons who develop acute lung injury and the acute respiratory distress syndrome. Ann Intern Med. 2002;136(1):25–36. doi:10.7326/0003-4819-136-1-200201010-00007.
   PubMed Web of Science ®Google Scholar
• Kling KM, Lopez-Rodriguez E, Pfarrer C, Muhlfeld C, Brandenberger C. Aging exacerbates acute lung injury-induced changes of the air-blood barrier, lung function, and inflammation in the mouse. Am J Physiol Lung Cell Mol Physiol. 2017;312(1):L1–Ll12. doi:10.1152/ajplung.00347.2016.
   PubMed Web of Science ®Google Scholar
• Brandenberger C, Kling KM, Vital M, Christian M. The role of pulmonary and systemic immunosenescence in acute lung injury. Aging Dis. 2018;9(4):553–565. doi:10.14336/ad.2017.0902.
   PubMed Web of Science ®Google Scholar
• Palumbo S, Shin YJ, Ahmad K, et al. Dysregulated Nox4 ubiquitination contributes to redox imbalance and age-related severity of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2017;312(3):L297–Ll308. doi:10.1152/ajplung.00305.2016.
   PubMed Web of Science ®Google Scholar
• Barnes RP, Fouquerel E, Opresko PL. The impact of oxidative DNA damage and stress on telomere homeostasis. Mech Ageing Dev. 2019;177:37–45. doi:10.1016/j.mad.2018.03.013.
   PubMed Web of Science ®Google Scholar
• Guo J, Huang X, Dou L, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther. 2022;7(1):391. doi:10.1038/s41392-022-01251-0.
   PubMed Web of Science ®Google Scholar
• Wu C, Evans CE, Dai Z, et al. Lipopolysaccharide-induced endotoxemia in corn oil-preloaded mice causes an extended course of lung injury and repair and pulmonary fibrosis: A translational mouse model of acute respiratory distress syndrome. PLoS One. 2017;12(3):e0174327. doi:10.1371/journal.pone.0174327.
   PubMed Web of Science ®Google Scholar
• Navarro S, Driscoll B. Regeneration of the aging lung: a mini-review. Gerontology. 2017;63(3):270–280. doi:10.1159/000451081.
   PubMed Web of Science ®Google Scholar
• Cho WK, Lee CG, Kim LK. COPD as a Disease of Immunosenescence. Yonsei Med J. 2019;60(5):407–413. doi:10.3349/ymj.2019.60.5.407.
   PubMed Web of Science ®Google Scholar
• Breen M, Nwanaji-Enwerem JC, Karrasch S, et al. Accelerated epigenetic aging as a risk factor for chronic obstructive pulmonary disease and decreased lung function in two prospective cohort studies. Aging (Albany NY). 2020;12(16):16539–16554. doi:10.18632/aging.103784.
   PubMedGoogle Scholar
• Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance–United States, 1999-2011. Chest. 2013;144(1):284–305. doi:10.1378/chest.13-0809.
   PubMed Web of Science ®Google Scholar
• Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–750. doi:10.1016/s0140-6736(07)61377-4.
   PubMed Web of Science ®Google Scholar
• Thannickal VJ, Murthy M, Balch WE, et al. Blue journal conference. Aging and susceptibility to lung disease. Am J Respir Crit Care Med. 2015;191(3):261–269. doi:10.1164/rccm.201410-1876PP.
   PubMed Web of Science ®Google Scholar
• Glass DS, Grossfeld D, Renna HA, et al. Idiopathic pulmonary fibrosis: Molecular mechanisms and ­potential treatment approaches. Respir Investig. 2020;58(5):320–335. doi:10.1016/j.resinv.2020.04.002.
   PubMed Web of Science ®Google Scholar
• Gao H, Xiao D, Gao L, Li X. MicroRNA‑93 contributes to the suppression of lung inflammatory responses in LPS‑induced acute lung injury in mice via the TLR4/MyD88/NF‑kappaB signaling pathway. Int J Mol Med. 2020;46(2):561–570. doi:10.3892/ijmm.2020.4610.
   PubMed Web of Science ®Google Scholar
• Mao B, Guo W, Tang X, et al. Inosine pretreatment attenuates LPS-induced lung injury through regulating the TLR4/MyD88/NF-kappaB signaling pathway in vivo. Nutrients. 2022;14(14):2830. doi:10.3390/nu14142830.
   PubMed Web of Science ®Google Scholar
• Hernández Borrero LJ, El-Deiry WS. Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. Biochim Biophys Acta Rev Cancer. 2021;1876(1):188556. doi:10.1016/j.bbcan.2021.188556.
   PubMed Web of Science ®Google Scholar
• Tabibzadeh S. Signaling pathways and effectors of aging. Front Biosci (Landmark Ed). 2021;26(1):50–96. doi:10.2741/4889.
   PubMed Web of Science ®Google Scholar
• Ostedgaard LS, Moninger TO, McMenimen JD, et al. Gel-forming mucins form distinct morphologic structures in airways. Proc Natl Acad Sci USA. 2017;114(26):6842–6847. doi:10.1073/pnas.1703228114.
   PubMed Web of Science ®Google Scholar
• Hancock LA, Hennessy CE, Solomon GM, et al. Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice. Nat Commun. 2018;9(1):5363. doi:10.1038/s41467-018-07768-9.
   PubMedGoogle Scholar
• Vaughan DE, Rai R, Khan SS, Eren M, Ghosh AK. Plasminogen activator inhibitor-1 is a marker and a mediator of senescence. Arterioscler Thromb Vasc Biol. 2017;37(8):1446–1452. doi:10.1161/atvbaha.117.309451.
   PubMed Web of Science ®Google Scholar
• Eren M, Boe AE, Klyachko EA, Vaughan DE. Role of plasminogen activator inhibitor-1 in senescence and aging. Semin Thromb Hemost. 2014;40(6):645–651. doi:10.1055/s-0034-1387883.
   PubMed Web of Science ®Google Scholar
• Tsangaris I, Tsantes A, Bonovas S, et al. The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS. Thromb Res. 2009;123(6):832–836. doi:10.1016/j.thromres.2008.07.018.
   PubMed Web of Science ®Google Scholar